In our cohort, the expression of PREX2 was downregulated in tumors as compared to adjacent normal tissues and was negatively associated with methylation beta value (Fig. S4b, c), suggesting PREX2 may be a tumor suppressor in ESCC. This evidence concerns the gene PREX2 and esophageal squamous cell carcinoma.